HMNC and Spruce Launch Phase 2 TAMARIND Trial to Explore Precision Treatment for Depression

HMNC Brain Health (“HMNC”), a global precision psychiatry biopharmaceutical company, in collaboration with Spruce Biosciences, Inc. (OTCQB: S...

July 23, 2025 | Wednesday | News
Roche’s Elecsys pTau181 Becomes First IVDR-Certified Blood Test to Rule Out Alzheimer’s Pathology

Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid pathology. The mini...

July 23, 2025 | Wednesday | News
Corteria Pharmaceuticals Advances Dual CRF2 Agonist Pipeline for Heart Failure and Obesity

Corteria Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of transformative therapies for heart failure and obesity, ...

July 22, 2025 | Tuesday | News
Sanofi Completes Acquisition of Blueprint Medicines, Strengthening Rare Immunology Portfolio

Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a p...

July 21, 2025 | Monday | News
EQT Acquires Majority Stake in Adalvo from Aztiq to Fuel Global Expansion

Adalvo was founded in 2018 by Aztiq and is one of the leading business-to-business pharmaceutical companies in Europe EQT will support Adalvo’s ...

July 21, 2025 | Monday | News
SpringWorks Wins EU Nod for EZMEKLY® in NF1-Related Tumours

SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced  that the European Commission (EC) granted conditi...

July 21, 2025 | Monday | News
Qualigen Secures Broad Patent Coverage for QN-302 Across Over 20 European Nations, India, China, and Russia

Qualigen Therapeutics, Inc. is announcing an update on patents granted in the first six months of 2025. The patent is Titled “Substitued Naphthalen...

July 17, 2025 | Thursday | News
AAVantgarde Receives FDA Clearance for AAVB-039 to Treat Stargardt Disease

AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases,  ann...

July 16, 2025 | Wednesday | News
Waters and BD Strike $17.5B Strategic Combination

Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution...

July 15, 2025 | Tuesday | News
CARsgen Secures Final EPO Win for GPC3 CAR-T Patent After Appeal Withdrawal

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces a favorable outco...

July 14, 2025 | Monday | News
iFIT and Samsung Health Partner to Redefine Connected Fitness and Personalised Healthcare Globally

iFIT, a global leader in connected fitness and interactive content,  announced a groundbreaking partnership with Samsung Health, one of the world&rs...

July 14, 2025 | Monday | News
EMA Lifts Age Restriction on Valneva’s Chikungunya Vaccine IXCHIQ® Following Safety Review

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company,  announced that the European Medicines Agency (EMA) will lift the tempo...

July 14, 2025 | Monday | News
Secarna and Vect-Horus Join Forces to Unlock RNA Therapeutics for CNS Disorders

  The partnership combines Secarna’s OligoCreator® technology with Vect-Horus’ VECTrans® platform to enable system...

July 11, 2025 | Friday | News
Angelini Ventures Co-Leads CHF79M Series B in NUCLIDIUM to Advance Copper-Based Radiotheranostics

  Angelini Ventures, the corporate venture firm of Angelini Industries focused on investing in companies developing innovative solutions in BioTech a...

July 11, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close